PET scans to spot early Alzheimer's changes
Part of Brain & nervous system, Mental health clinical trials.
This trial uses special PET scans to see amyloid and tau proteins in the brain, which are linked to Alzheimer's. It aims to find these changes early, in people with mild memory problems or early-stage Alzheimer's.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have mild memory problems that started slowly and got worse over time, but you don't have full dementia.
- Your memory loss is clear, and you may also have trouble with other thinking skills like planning or language.
- You have a score of 0.5 on the Clinical Dementia Rating scale (this means very mild cognitive changes).
- You do not have a history of stroke, major brain disease (like Parkinson's or epilepsy), or untreated medical conditions that could affect your memory (like thyroid problems or vitamin deficiency).
- You are not currently depressed or taking drugs/alcohol that might confuse the results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET scan to take pictures of abnormal tau protein in the brain. It aims to see if the scan results match what is found in brain tissue after death, which could help improve diagnosis of Alzheimer's and related conditions.
This study uses a special brain scan (tau PET/CT) to look for a protein called tau, and it ties the scan results to information collected in an existing research program. It may help researchers better understand brain changes over time.
This study uses special brain scans (PET scans) to look for proteins linked to Alzheimer's disease. It aims to improve diagnosis and track how the disease progresses over time.
This trial uses a new type of PET scan to look for specific proteins in the brain that are linked to Alzheimer's disease. It will help doctors see how these proteins relate to cognitive decline and compare scans from people with normal thinking to those with memory problems.
This study uses brain scans to see how anti-amyloid treatments affect tau protein buildup in people with early Alzheimer's. If you have mild cognitive impairment or mild Alzheimer's, you may be eligible to help understand how these treatments work.
This study is looking for healthy volunteers to help detect the very earliest signs of Alzheimer's disease—before memory loss starts. You will have tests like memory checks, blood draws, brain scans, and a spinal tap to look for Alzheimer's-related changes.
Hear when a new Alzheimer’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.